PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
21.62%
Revenue growth of 21.62% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
39.20%
Gross profit growth of 39.20% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
-255.04%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-255.04%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
102.01%
Net income growth of 102.01% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
60.99%
EPS growth exceeding 1.5x Healthcare median of 2.70%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
101.35%
Diluted EPS growth exceeding 1.5x Healthcare median of 2.47%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
16.05%
Share growth above Healthcare median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
14.82%
Diluted share growth above 2x Healthcare median. Jim Chanos would suspect undue issuance or heavy employee stock compensation.
No Data
No Data available this quarter, please select a different quarter.
-96.29%
Negative OCF growth while Healthcare median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-212.61%
Negative FCF growth while Healthcare median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6217.76%
3Y CAGR of 6217.76% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
103.53%
OCF/share CAGR of 103.53% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
112.04%
OCF/share CAGR of 112.04% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
102.33%
3Y OCF/share growth of 102.33% while Healthcare median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
387.66%
Net income/share CAGR exceeding 1.5x Healthcare median of 28.45% over a decade. Joel Greenblatt might see a standout compounder of earnings.
2084.63%
5Y net income/share CAGR > 1.5x Healthcare median of 21.05%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
232.29%
3Y net income/share CAGR > 1.5x Healthcare median of 13.70%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
2867.95%
Equity/share CAGR of 2867.95% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
4806.10%
5Y equity/share CAGR of 4806.10% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
1601.21%
3Y equity/share CAGR of 1601.21% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
830.66%
AR growth of 830.66% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
36.09%
Inventory growth of 36.09% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
95.84%
Asset growth of 95.84% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
66.82%
BV/share growth of 66.82% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
19.54%
Debt growth of 19.54% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
38.52%
R&D growth of 38.52% while Healthcare median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
69.20%
SG&A growth of 69.20% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.